Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Journal article
Watson JA. et al, (2024), eLife, 13
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Journal article
Pukrittayakamee S. et al, (2024), eLife, 12
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
Journal article
Adam I. et al, (2022), Wellcome Open Research, 7, 136 - 136
An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.
Journal article
MalariaGEN None. et al, (2022), Wellcome open research, 7
The prevention and treatment of Plasmodium vivax malaria.
Journal article
Chu CS. and White NJ., (2021), PLoS medicine, 18
Tafenoquine: a toxicity overview.
Journal article
Chu CS. and Hwang J., (2020), Expert Opin Drug Saf
Vivax malaria in pregnancy and lactation: a long way to health equity
Journal article
Brummaier T. et al, (2020), Malaria Journal, 19
Plasmodium-infected erythrocytes induce secretion of IGFBP7 to form type II rosettes and escape phagocytosis.
Journal article
Lee W-C. et al, (2020), eLife, 9
Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure
Journal article
Chu CS. et al, (2020), The American Journal of Tropical Medicine and Hygiene, 102, 147 - 150
Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter.
Journal article
Chu CS. et al, (2020), Wellcome open research, 5
Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
Journal article
Taylor AR. et al, (2019), Nature Communications, 10
Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion
Journal article
Bancone G. et al, (2019), Malaria Journal, 18
Retrospective Review of Documentation Practices of Hepatitis B Immunoglobulin, Birth Dose, and Vaccination at the Hospital of Birth, in Thai Nationals and Migrants in Northern Thailand
Journal article
Bierhoff M. et al, (2019), Open Forum Infectious Diseases, 6
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2019), BMC Medicine, 17
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928
Tafenoquine and G6PD: a primer for clinicians.
Journal article
Chu CS. and Freedman DO., (2019), Journal of travel medicine, 26
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
Journal article
Chu CS. et al, (2019), Wellcome Open Research, 4, 25 - 25
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Journal article
Chu CS. et al, (2019), Clinical Infectious Diseases, 68, 1311 - 1319
Maternal Hepatitis B Infection Burden, Comorbidity and Pregnancy Outcome in a Low-Income Population on the Myanmar-Thailand Border: A Retrospective Cohort Study
Journal article
Bierhoff M. et al, (2019), Journal of Pregnancy, 2019, 1 - 11